Retinaldehyde represses adipogenesis and diet-induced obesity

Area of Science:

• Metabolic regulation
• Vitamin A metabolism
• Obesity and insulin resistance research

Background:

• Vitamin A metabolites, including retinoic acid, are crucial for cellular differentiation and metabolism.
• Retinoic acid acts through nuclear receptors like retinoic acid receptor and retinoid X receptor (RXR).
• Retinaldehyde (Rald), a precursor to retinoic acid, was previously thought to have no biological role outside the eye.

Purpose of the Study:

• To investigate the potential biological role of retinaldehyde (Rald) beyond the eye.
• To determine Rald's function in adipogenesis and metabolic regulation.
• To explore the therapeutic potential of targeting Rald or its catabolizing enzymes in metabolic diseases.

Main Methods:

• Detection and characterization of Rald in rodent adipose tissue.
• Assessment of Rald's binding to retinol-binding proteins (CRBP1, RBP4).
• In vitro assays to evaluate Rald's effects on adipogenesis and nuclear receptor activity.
• In vivo studies using Raldh1-deficient mice and ob/ob mice treated with Rald or a Raldh inhibitor.

Main Results:

• Retinaldehyde (Rald) is present in rodent fat and binds to CRBP1 and RBP4.
• Rald inhibits adipogenesis and suppresses peroxisome proliferator-activated receptor-gamma and RXR signaling.
• Mice lacking Raldh1 exhibited resistance to diet-induced obesity and insulin resistance, with increased energy expenditure.
• Administration of Rald or a Raldh inhibitor to ob/ob mice reduced fat mass and improved insulin sensitivity.

Conclusions:

• Retinaldehyde (Rald) possesses a distinct biological role in regulating metabolic responses, particularly to high-fat diets.
• Rald acts as a transcriptional regulator influencing adipogenesis and energy metabolism.
• Targeting Rald or Raldh1 presents a potential therapeutic strategy for managing obesity and insulin resistance.